(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PLUS THERAPEUTICS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

PLUS THERAPEUTICS

ST13

US500000088470736

Class

42

Filing

88470736

Registration

7795597

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

73

Latest update

05/13/2025

Trademark type

Word

Nice classes

42

Filing date

06/12/2019

Registration date

05/13/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/13/2025

Last transaction

05/13/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

05/06/2022

First use in commerce

05/06/2022

Drawing code

4

Owner type

03

Owner location

Austin, TX

Examiner

NKOJO, RHODA

Law office

M80

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

PLUS THERAPEUTICS, INC.
Cytori Therapeutics, Inc.

Representatives

IAN W. GILLIES KNOBBE, MARTENS, OLSON & BEAR, LLP

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Providing medical and scientific information in the field of cancerautoimmune diseases and disordersorthopedic diseases and disordersblood diseases and disordersdiseases and disorders of the central nervous systemoncological diseases and disordersophthalmological diseases and disorders

Publications

History of USPTO decisions and trademark events.

73 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

05/13/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

05/13/2025

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

04/17/2025

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

04/17/2025

XAEC

EXAMINER'S AMENDMENT ENTERED

04/17/2025

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

04/17/2025

GNEA

EXAMINERS AMENDMENT E-MAILED

04/17/2025

SNEA

SU-EXAMINER'S AMENDMENT WRITTEN

04/17/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

03/12/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/12/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/12/2025

ALIE

ASSIGNED TO LIE

03/12/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/28/2025

XELG

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

11/25/2024

XELR

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

11/25/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/02/2024

GNRT

NON-FINAL ACTION E-MAILED

09/02/2024

CNRT

SU - NON-FINAL ACTION - WRITTEN

09/02/2024

SUPC

STATEMENT OF USE PROCESSING COMPLETE

07/09/2024

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

01/05/2024

IUAF

USE AMENDMENT FILED

12/28/2023

EISU

TEAS STATEMENT OF USE RECEIVED

12/28/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

06/23/2023

EX5G

SOU EXTENSION 5 GRANTED

06/22/2023

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

06/22/2023

EXT5

SOU EXTENSION 5 FILED

06/15/2023

EEXT

SOU TEAS EXTENSION RECEIVED

06/15/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

12/10/2022

EX4G

SOU EXTENSION 4 GRANTED

12/08/2022

EXT4

SOU EXTENSION 4 FILED

12/08/2022

EEXT

SOU TEAS EXTENSION RECEIVED

12/08/2022

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

10/26/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

05/20/2022

EX3G

SOU EXTENSION 3 GRANTED

05/18/2022

EXT3

SOU EXTENSION 3 FILED

05/18/2022

EEXT

SOU TEAS EXTENSION RECEIVED

05/18/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

12/23/2021

EX2G

SOU EXTENSION 2 GRANTED

12/21/2021

EXT2

SOU EXTENSION 2 FILED

12/21/2021

EEXT

SOU TEAS EXTENSION RECEIVED

12/21/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

06/29/2021

EX1G

SOU EXTENSION 1 GRANTED

06/25/2021

EXT1

SOU EXTENSION 1 FILED

06/25/2021

EEXT

SOU TEAS EXTENSION RECEIVED

06/25/2021

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

12/29/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/03/2020

PUBO

PUBLISHED FOR OPPOSITION

11/03/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/14/2020

EXPT

EXPARTE APPEAL TERMINATED

09/25/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/25/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/25/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/25/2020

ALIE

ASSIGNED TO LIE

09/25/2020

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

09/23/2020

EXPI

EX PARTE APPEAL-INSTITUTED

09/23/2020

JURT

JURISDICTION RESTORED TO EXAMINING ATTORNEY

09/23/2020

EXAF

EXPARTE APPEAL RECEIVED AT TTAB

09/23/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

07/28/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/28/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

07/28/2020

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

04/01/2020

GNFR

FINAL REFUSAL E-MAILED

04/01/2020

CNFR

FINAL REFUSAL WRITTEN

04/01/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/10/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/09/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/09/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/12/2019

GNRT

NON-FINAL ACTION E-MAILED

09/12/2019

CNRT

NON-FINAL ACTION WRITTEN

09/12/2019

DOCK

ASSIGNED TO EXAMINER

09/04/2019

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

08/14/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/25/2019

NWAP

NEW APPLICATION ENTERED

06/15/2019

Continuous trademark protection

Get notified about every new filing that threatens PLUS THERAPEUTICS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.